Celcuity (CELC) Common Equity (2016 - 2025)
Celcuity (CELC) posted Common Equity of $100.6 million for Q4 2025, down 14.03% on a QoQ basis from $117.0 million in Q3 2025, and down 13.03% year-over-year from $115.6 million in Q4 2024.
Celcuity (CELC) Common Equity (2016 - 2025) Analysis & Trends
Celcuity's Common Equity history runs 10 years deep, the most recent figure standing at $100.6 million for Q4 2025.
- Quarterly Common Equity fell 13.03% year-over-year to $100.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $100.6 million (down 13.03% YoY) and the FY2025 annual result came in at $100.6 million, down 13.03% from the prior year.
- Common Equity was $100.6 million for Q4 2025 at Celcuity, down from $117.0 million in the prior quarter.
- Across five years, Common Equity topped out at $176.7 million in Q2 2024 and bottomed at $27.0 million in Q2 2021.
- A 5-year average of $94.4 million and a median of $96.7 million in 2023 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2021 — Common Equity jumped 487.16% — and 2025, when it sank 74.88%.
- Celcuity's Common Equity stood at $68.7 million in 2021, then surged by 94.69% to $133.8 million in 2022, then climbed by 4.48% to $139.8 million in 2023, then decreased by 17.28% to $115.6 million in 2024, then dropped by 13.03% to $100.6 million in 2025.
- Business Quant data shows CELC's Common Equity at $100.6 million in Q4 2025, $117.0 million in Q3 2025, and $44.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Celcuity | 4.13 Bn | 4.13 Bn | - | 100.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 100.56 Mn |
| Sep 30, 2025 | 116.96 Mn |
| Jun 30, 2025 | 44.38 Mn |
| Mar 31, 2025 | 86.67 Mn |
| Dec 31, 2024 | 115.62 Mn |
| Sep 30, 2024 | 149.71 Mn |
| Jun 30, 2024 | 176.69 Mn |
| Mar 31, 2024 | 133.74 Mn |
| Dec 31, 2023 | 139.77 Mn |
| Sep 30, 2023 | 92.90 Mn |
| Jun 30, 2023 | 110.13 Mn |
| Mar 31, 2023 | 123.23 Mn |
| Dec 31, 2022 | 133.77 Mn |
| Sep 30, 2022 | 43.53 Mn |
| Jun 30, 2022 | 53.19 Mn |
| Mar 31, 2022 | 61.54 Mn |
| Dec 31, 2021 | 68.71 Mn |
| Sep 30, 2021 | 74.47 Mn |
| Jun 30, 2021 | 27.03 Mn |
| Mar 31, 2021 | 35.17 Mn |